The Effects of Lifebloom One on Physical Activity After Acquired Brain Injury (LBO_LCA)

Lifebloom

Status: Completed

Conditions: Stroke; Brain Injuries, Traumatic

Treatments: Device: Lifebloom One

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT05977270

2021-A00072-39

Details and patient eligibility

About

The goal of this clinical trial is to evaluate the effects of Lifebloom One in people who have suffered a stroke or a traumatic brain injury.

The main questions to be answered are:

• Does Lifebloom One allow users to spend more time standing each day?
• Does Lifebloom One allow users to improve their balance and gait?

Participants will use Lifebloom One during 8 weeks.

For each participant, gait and balance are compared either with and without Oxilio or before and after Lifebloom One intervention.

Enrollment: 5 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Stroke or traumatic brain injury more than 2 months old
• Unable to walk without assistance
• Expected length of stay equal to or greater than 4 months

Exclusion criteria

• Anthropometric incompatibility with Oxilio
• Unable to walk prior to brain injury
• No functional upper limb
• Complete sensory deficit in the lower limb(s)
• Degenerative impairment (tumor, neurodegenerative disease, etc.)

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

5 participants in 1 patient group

Lifebloom One intervention

Experimental group

Treatment:

Device: Lifebloom One